Search Results - "Buss, Mary"

Reflections on Palliative Medicine Turning Sweet Sixteen by Buss, Mary K.

Get full text

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study by Liu, Joyce F, Dr, Barry, William T, PhD, Birrer, Michael, MD, Lee, Jung-Min, MD, Buckanovich, Ronald J, MD, Fleming, Gini F, Prof, Rimel, BJ, MD, Buss, Mary K, MD, Nattam, Sreenivasa, MD, Hurteau, Jean, MD, Luo, Weixiu, MS, Quy, Philippa, MA, Whalen, Christin, BSN, Obermayer, Lisa, BA, Lee, Hang, PhD, Winer, Eric P, Prof, Kohn, Elise C, MD, Ivy, S Percy, MD, Matulonis, Ursula A, MD

“…Summary Background Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is an anti-angiogenic agent with activity against VEGF receptor (VEGFR) 1,…”
Get full text

Understanding Palliative Care and Hospice: A Review for Primary Care Providers by Buss, Mary K, Rock, Laura K, McCarthy, Ellen P

“…Palliative care provides invaluable clinical management and support for patients and their families. For most people, palliative care is not provided by…”
Get full text

Should Outpatient Palliative Care Clinics in Cancer Centers be Stand Alone or Embedded? by Zimmermann, Camilla, Buss, Mary K., Rabow, Michael W., Hannon, Breffni, Hui, David

“…Outpatient palliative care facilitates timely symptom management, psychosocial care and care planning. A growing number of cancer centers have either…”
Get full text

Delivering Palliative Care to Hospitalized Oncology Patients: A Scoping Review by Han, Harry J., Yeh, Jonathan C., McNichol, Megan, Buss, Mary K.

“…Early, longitudinal integration of palliative care (PC) is recommended for patients with advanced cancer, in both inpatient and outpatient settings. Despite…”
Get full text

Financial toxicity in gynecologic oncology by Bouberhan, Sara, Shea, Meghan, Kennedy, Alice, Erlinger, Adrienne, Stack-Dunnbier, Hannah, Buss, Mary K., Moss, Laureen, Nolan, Kathleen, Awtrey, Christopher, Dalrymple, John L., Garrett, Leslie, Liu, Fong W., Hacker, Michele R., Esselen, Katharine M.

“…Financial toxicity is increasingly recognized as an adverse outcome of cancer treatment. Our objective was to measure financial toxicity among gynecologic…”
Get full text

Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial by Konstantinopoulos, Panagiotis A, Barry, William T, Birrer, Michael, Westin, Shannon N, Cadoo, Karen A, Shapiro, Geoffrey I, Mayer, Erica L, O'Cearbhaill, Roisin E, Coleman, Robert L, Kochupurakkal, Bose, Whalen, Christin, Curtis, Jennifer, Farooq, Sarah, Luo, Weixiu, Eismann, Julia, Buss, Mary K, Aghajanian, Carol, Mills, Gordon B, Palakurthi, Sangeetha, Kirschmeier, Paul, Liu, Joyce, Cantley, Lewis C, Kaufmann, Scott H, Swisher, Elizabeth M, D'Andrea, Alan D, Winer, Eric, Wulf, Gerburg M, Matulonis, Ursula A

“…Based on preclinical work, we found that combination of poly (ADP-ribose) polymerase (PARP) inhibitors with drugs that inhibit the homologous recombination…”
Get full text

Pro-active Palliative Care for Hospitalized Primary Care Patients by Lien, Cindy, Shapiro, Samantha, Dodge, Laura E., Currier, Carrie, Buss, Mary K.

“…Early integration of palliative care (PC) improves outcomes for patients with cancer and heart failure. Data on the role of PC in complex general medicine…”
Get full text

Outpatient Training During Hospice and Palliative Medicine Fellowship: A National Survey by Han, Harry J., Ouellette, Michelle C., Yeh, Jonathan C., Dodge, Laura E., Finlay, Esme, Cullinan, Amelia M., Buss, Mary K.

“…Outpatient palliative care (PC) has strong evidence demonstrating impact across serious illnesses, resulting in growing demand for skilled outpatient PC…”
Get full text

A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer by Liu, Joyce F, Tolaney, Sara M, Birrer, Michael, Fleming, Gini F, Buss, Mary K, Dahlberg, Suzanne E, Lee, Hang, Whalen, Christin, Tyburski, Karin, Winer, Eric, Ivy, Percy, Matulonis, Ursula A

“…Abstract Background Poly(ADP-ribose) polymerase (PARP)-inhibitors and anti-angiogenics have activity in recurrent ovarian and breast cancer; however, the…”
Get full text

Palliative Medicine Fellows’ Discussions, Perceptions, and Training Regarding Medical Cannabis by Sherry, Dylan R., Patell, Rushad, Han, Harry J., Dodge, Laura E., Braun, Ilana M., Buss, Mary K.

“…Medical cannabis is increasingly considered for palliation of pain, nausea/vomiting, anorexia, and other symptoms. We aimed to determine whether training in…”
Get full text

Palliative Oncologists: Specialists in the Science and Art of Patient Care by Hui, David, Finlay, Esmé, Buss, Mary K, Prommer, Eric E, Bruera, Eduardo

Get full text

CHESS Improves Cancer Caregivers' Burden and Mood: Results of an eHealth RCT by DuBenske, Lori L., Gustafson, David H., Namkoong, Kang, Hawkins, Robert P., Atwood, Amy K., Brown, Roger L., Chih, Ming-Yuan, McTavish, Fiona, Carmack, Cindy L., Buss, Mary K., Govindan, Ramaswamy, Cleary, James F.

“…Objective: Informal caregivers (family and friends) of people with cancer are often unprepared for their caregiving role, leading to increased burden or…”
Get full text

Does Use of Information Sources Outside the Treating Oncologist Influence Patient Decision-Making in Patients Receiving Non-Curative Intent Therapy for Advanced Cancer by Patell, Rushad, Miller, Eric, Einstein, David, Dodge, Laura E., Halleck, Jennifer, Buss, Mary K.

“…Background Patients’ decision-making and perceptions of outcomes may be impacted by information sources. We investigated use of information by patients and…”
Get full text

Palliative Care Education for Surgical Residents: Current Practices and Future Directions by Allar, Benjamin G., Weinstock, Judy, Buss, Mary K., Kent, Tara S.

“…Despite the benefits and increased clinical application of primary palliative care principles within surgery, palliative care education among surgical trainees…”
Get full text

Would You Refer This Patient With Cancer to a Palliative Care Specialist? by Reynolds, Eileen E, Buss, Mary K, Schlechter, Benjamin L

Get full text

The Intersection of Palliative Care and Interventional Radiology: Enhancing Understanding and Collaboration by Buss, Mary K

“…In the treatment of cancer patients, many interventional radiologic procedures are palliative in nature. The goal for these therapies is often something other…”
Get full text

Would You Refer This Patient With Cancer to a Palliative Care Specialist?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center by Reynolds, Eileen E, Buss, Mary K, Schlechter, Benjamin L, Tess, Anjala

“…In 2016, the American Society of Clinical Oncology published a guideline recommending that all patients with advanced cancer be referred to palliative care…”
Get full text

Integrating palliative care into the evolving landscape of oncology by Han, Harry J, Pilgrim, Carol R, Buss, Mary K

“…Patients with cancer have many palliative care needs. Robust evidence supports the early integration of palliative care into the care of patients with advanced…”
Get full text

Are Opioid Infusions Used Inappropriately at End of Life? Results From a Quality/Safety Project by Yeh, Jonathan C., Chae, Sul Gi, Kennedy, Peter J., Lien, Cindy, Malecha, Patrick W., Han, Harry J., Buss, Mary K., Lee, Kathleen A.

“…Opioid continuous infusions are commonly used for end-of-life (EOL) symptoms in hospital settings. However, prescribing practices vary, and even the recent…”
Get full text